Cargando…

U0126: Not only a MAPK kinase inhibitor

U0126, as an inhibitor of the MAPK signaling pathway, is closely related to various biological processes, such as differentiation, cell growth, autophagy, apoptosis, and stress responses. It makes U0126 play an essential role in balancing cellular homeostasis. Although U0126 has been suggested to in...

Descripción completa

Detalles Bibliográficos
Autores principales:	You, Yijie, Niu, Yunlian, Zhang, Jian, Huang, Sheng, Ding, Peiyuan, Sun, Fengbing, Wang, Xuhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452634/ https://www.ncbi.nlm.nih.gov/pubmed/36091807 http://dx.doi.org/10.3389/fphar.2022.927083

Ejemplares similares

Impact of COVID-19 pandemic on haemorrhagic stroke admissions: a systematic review and meta-analysis
por: You, Yijie, et al.
Publicado: (2021)

Three-dimensional printing and 3D slicer powerful tools in understanding and treating neurosurgical diseases
por: You, Yijie, et al.
Publicado: (2022)

Nonwoven-based gelatin/polycaprolactone membrane loaded with ERK inhibitor U0126 for treatment of tendon defects
por: Hou, Yonghui, et al.
Publicado: (2022)

Potent block of potassium channels by MEK inhibitor U0126 in primary cultures and brain slices
por: Wang, Jin-Zhao, et al.
Publicado: (2018)

The small molecule Mek1/2 inhibitor U0126 disrupts the chordamesoderm to notochord transition in zebrafish
por: Hawkins, Thomas A, et al.
Publicado: (2008)

U0126 Protects Cells against Oxidative Stress Independent of Its Function as a MEK Inhibitor
por: Ong, Qunxiang, et al.
Publicado: (2014)

The MEK inhibitor U0126 ameliorates diabetic cardiomyopathy by restricting XBP1's phosphorylation dependent SUMOylation
por: Wang, Tao, et al.
Publicado: (2021)

MEK Inhibitor U0126 Reverses Protection of Axons from Wallerian Degeneration Independently of MEK–ERK Signaling
por: Evans, Catherine, et al.
Publicado: (2013)

The ERK(1/2) Inhibitor U0126 Attenuates Diabetes-Induced Upregulation of MMP-9 and Biomarkers of Inflammation in the Retina
por: Mohammad, Ghulam, et al.
Publicado: (2013)

Synergistic growth inhibition of anaplastic large cell lymphoma cells by combining cellular ALK gene silencing and a low dose of the kinase inhibitor U0126
por: Ito, M, et al.
Publicado: (2010)

U0126 Compound Triggers Thermogenic Differentiation in Preadipocytes via ERK-AMPK Signaling Axis
por: Onikanni, Sunday Amos, et al.
Publicado: (2023)

MEK1/2 inhibitor U0126, but not nimodipine, reduces upregulation of cerebrovascular contractile receptors after subarachnoid haemorrhage in rats
por: Christensen, Simon T., et al.
Publicado: (2019)

Production of Japanese Black calves by the transfer of embryos developed from in vitro-fertilized oocytes derived by ovum pick up and matured in culture with the mitogen-activated protein kinase kinase inhibitor U0126
por: SAKAGAMI, Nobutada, et al.
Publicado: (2019)

PA01.26. Clinical application of quantum physics in ayurveda
por: Gandhi, Manaan, et al.
Publicado: (2012)

Synergistic effects of a cremophor EL drug delivery system and its U0126 cargo in an ex vivo model
por: Christensen, S. T., et al.
Publicado: (2019)

Effects of U0126 and MK2206 on cell growth and re-growth of endometriotic stromal cells grown on substrates of varying stiffness
por: Matsuzaki, Sachiko, et al.
Publicado: (2017)

Advances in RIPK1 kinase inhibitors
por: Chen, Lu, et al.
Publicado: (2022)

Prophylactic cognitive enhancers for improvement of cognitive function in patients undergoing electroconvulsive therapy: A systematic review and meta-analysis
por: Niu, Yunlian, et al.
Publicado: (2020)

Combination treatment with U0126 and rt-PA prevents adverse effects of the delayed rt-PA treatment after acute ischemic stroke
por: Orset, Cyrille, et al.
Publicado: (2021)

Modulation of Osteogenic Differentiation of Adipose-Derived Stromal Cells by Co-Treatment with 3, 4’-Dihydroxyflavone, U0126, and N-Acetyl Cysteine
por: Song, Kwonwoo, et al.
Publicado: (2022)

U0126 and BAY11-7082 Inhibit the Progression of Endometriosis in a Rat Model by Suppressing the MEK/ERK/NF-κB Pathway
por: Wang, Fang, et al.
Publicado: (2023)

The Kinase Specificity of Protein Kinase Inhibitor Peptide
por: Chen, Yao, et al.
Publicado: (2021)

OA01.26. Evaluation of tablet hrudayrog chintamani in management of coronary artery disease
por: Palshetkar, Rahul, et al.
Publicado: (2012)

Study on the Characteristics of Small-Molecule Kinase Inhibitors-Related Drug-Induced Liver Injury
por: Dong, Huiqun, et al.
Publicado: (2022)

Erratum: Advances in RIPK1 kinase inhibitors
Publicado: (2023)

Immunomodulatory Effects of Colistin on Macrophages in Rats by Activating the p38/MAPK Pathway
por: Wang, Jin, et al.
Publicado: (2019)

Elevated ABCB1 Expression Confers Acquired Resistance to Aurora Kinase Inhibitor GSK-1070916 in Cancer Cells
por: Wu, Zhuo-Xun, et al.
Publicado: (2021)

Drug Signature-based Finding of Additional Clinical Use of LC28-0126 for Neutrophilic Bronchial Asthma
por: Shin, Eunji, et al.
Publicado: (2015)

Eupatilin attenuates the senescence of nucleus pulposus cells and mitigates intervertebral disc degeneration via inhibition of the MAPK/NF-κB signaling pathway
por: Yang, Huan, et al.
Publicado: (2022)

The role of irreversible pan-HER tyrosine kinase inhibitors in the treatment of HER2-Positive metastatic breast cancer
por: Wu, Zihong, et al.
Publicado: (2023)

Loss of MHC-I antigen presentation correlated with immune checkpoint blockade tolerance in MAPK inhibitor-resistant melanoma
por: Yu, Jing, et al.
Publicado: (2022)

Safety and efficacy of p38 mitogen-activated protein kinase inhibitors (MAPKIs) in COPD
por: Yu, Haichuan, et al.
Publicado: (2022)

Selective STAT3 Inhibitor Alantolactone Ameliorates Osteoarthritis via Regulating Chondrocyte Autophagy and Cartilage Homeostasis
por: Pei, Wenbin, et al.
Publicado: (2021)

EHMTI-0126. Superiority of algopirin® versus excedrin® in treating migraine. Individual pain values and pain curves comparisons
por: Mircioiu, C, et al.
Publicado: (2014)

Kinase Inhibitors as Potential Therapeutic Agents in the Treatment of COVID-19
por: Naik, Rajashri R., et al.
Publicado: (2022)

Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma
por: Jiang, Lei, et al.
Publicado: (2023)

Exploring the chemotherapeutic potential of currently used kinase inhibitors: An update
por: Naik, Rajashri R., et al.
Publicado: (2023)

Gastrodin Inhibits Virus Infection by Promoting the Production of Type I Interferon
por: Zhou, Yunlian, et al.
Publicado: (2021)

Chondro-Protective Effects of Shikimic Acid on Osteoarthritis via Restoring Impaired Autophagy and Suppressing the MAPK/NF-κB Signaling Pathway
por: You, Hongbo, et al.
Publicado: (2021)

Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitor-Associated Cardiotoxicity: A Recent Five-Year Pharmacovigilance Study
por: Liu, Yihan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i95ng06e6b05g56n1i3hkvgen9